Population-based examination of substance use disorders and treatment use among US young adults in the National Survey on Drug Use and Health, 2011–2019

Effects of recent cannabis consumption on eye-tracking and pupillometry

“…Historically, cannabis and its derivatives have been classified as a Schedule I controlled substance in the United States ( Mead, 2019 ), but recent changes in laws have approved its medical and recreational use in several States ( Smart and Pacula, 2019 ; Blanchette et al, 2022 ). With its increased popularity of legal and illegal consumption ( Lu et al, 2023 ), there is an increased interest in identifying methods to identify if a person is currently under the influence of cannabis or not, such as at work ( Macdonald et al, 2010 ) or while driving ( Martin et al, 2017 ). According to National Institutes of Justice, biofluid quantification of cannabis metabolites are unreliable markers of recent use ( National Institute of Justice, 2021 ), which may be attributed to their complex metabolism and lipophilic nature ( Chayasirisobhon, 2020 ), different modes of consumption ( Newmeyer et al, 2017 ; Zipursky et al, 2020 ), as well as the use of synthetic forms of cannabis ( Tagen and Klumpers, 2022 ).…”

Evaluating mobile harm reduction services for youth and young adults

“…Harm reduction practices and medication for opioid use disorder (MOUD) have the potential to reduce drug-related morbidity and mortality including infections, overdose, and death. AYA are less likely to engage in substance use disorder (SUD) treatment, and though they can benefit from harm reduction services, they engage differently with these services compared to adults ( 3 ). Specifically, AYA are less likely to access harm reduction resources and may rely on social networks to reduce risk, such as using substances in the presence of others ( 4 ).…”